Zenith Healthcare Ltd is engaged in trading and manufacturing of pharmaceutical products.Product Profile: a) Pharmaceutical Pills: Alprazolam & Propranolol HCL Tablets, Pantoprazole Sodium Levosulpiride Capsules, Vicadol, Mdzime b) Pharmaceutical Syrup And Protein Powder: Azithromycin Dihydrate Suspension, Cofzen Syrup, Domperidone Suspension, Zenoset Syrup, Valprex Syrup c) Oral Rehydration Salt: Albendazole Oral...
Zenith Healthcare has reappointed Mrs. Neela M. Raycha as a Non-Executive Director. She has served on the board since 2001 and was eligible for re-appointment after retiring by rotation. Mrs. Raycha, a Science Graduate, brings expertise in Quality Control and Product Development. She holds 1,261,712 shares in the company and...
Zenith Healthcare's shareholders have regularized Mr. Akshit M. Raycha as Joint Managing Director/Whole Time Director at the 32nd Annual General Meeting. Appointed for a three-year term until April 2029, he holds an MBA from Cambridge and brings extensive experience in management, export, and retail, having initiated several new company ventures....
Zenith Healthcare Limited re-appointed Mr. Mahendra C. Raycha as Managing Director for another three-year term, effective from July 1, 2026, to June 30, 2029. This decision was approved by a special resolution at the 32nd Annual General Meeting. As a promoter, Mr. Raycha holds 0.66 Cr equity shares, representing 12.29%...
Voting Result at the 32nd Annual General Meeting of the Company and Scrutinizer''s Report-Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015
Zenith Healthcare Limited’s 32nd Annual General Meeting successfully concluded with key shareholder approvals. Members adopted the audited financial statements for the year ended 31st March, 2026. They also re-appointed Mrs. Neela M. Raycha as Director, and approved the re-appointment of Mr. Mahendra C. Raycha as Managing Director and Mr. Akshit...
